During the past decade, Fujian Medical University Union Hospital conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 29 clinical trials were completed, i.e. on average, 13.5% percent of trials that started reached the finish line to date. In the past 5 years, 111 clinical trials started and 24 clinical trials were completed. i.e. 21.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fujian Medical University Union Hospital" #1 sponsor was "Fujian Medical University" with 45 trials, followed by "Fujian Medical University Union Hospital" with 18 trials sponsored, "BeiGene" with 15 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored and "Janssen Research & Development, LLC" with 15 trials sponsored. Other sponsors include 130 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fujian Medical University Union Hospital" #1 collaborator was "Fujian Medical University Union Hospital" with 13 trials as a collaborator, "Chinese PLA General Hospital" with 9 trials as a collaborator, "RenJi Hospital" with 7 trials as a collaborator, "The First Affiliated Hospital of Nanchang University" with 7 trials as a collaborator and "The First Hospital of Jilin University" with 7 trials as a collaborator. Other collaborators include 420 different institutions and companies that were collaborators in the rest 242 trials.

According to Clinical.Site data, the most researched conditions in "Fujian Medical University Union Hospital" are "Gastric Cancer" (15 trials), "Stomach Neoplasms" (13 trials), "Breast Cancer" (11 trials), "Coronary Artery Disease" (6 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Fujian Medical University Union Hospital" in a lesser frequency.

Most popular intervention types in "Fujian Medical University Union Hospital" are "Drug" (156 trials), "Procedure" (39 trials), "Biological" (16 trials), "Other" (13 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Tislelizumab" (10 trials), "Cyclophosphamide" (8 trials), "Carboplatin" (6 trials) and "Doxorubicin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Fujian Medical University Union Hospital" are 228 trials for "All" genders, 6 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 125 active trials in "Fujian Medical University Union Hospital". 7 are not yet recruiting, 68 are recruiting, 41 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 48 completed trials in Fujian Medical University Union Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fujian Medical University Union Hospital, 11 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 38 trials that are defined as “Not Applicable".